De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival
M. Mittelbronn*, D. Capper, B. Bunz, K. Dietz, B. Goeppert, R. Ajaaj, G. Tabatabai, F. Stubenvoll, H. Schlaszus, A. S. Merseburger, R. Becker, D. Freudenstein, W. Wick, M. Weller, R. Meyermann, P. Simon
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
18Citations
(Scopus)
Fingerprint
Dive into the research topics of 'De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival'. Together they form a unique fingerprint.